These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 10381666
1. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy. Kupersmith MJ, Langer R, Mitnick H, Spiera R, Spiera H, Richmond M, Paget S. Br J Ophthalmol; 1999 Jul; 83(7):796-801. PubMed ID: 10381666 [Abstract] [Full Text] [Related]
2. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Danesh-Meyer H, Savino PJ, Gamble GG. Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780 [Abstract] [Full Text] [Related]
5. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Foroozan R, Deramo VA, Buono LM, Jayamanne DG, Sergott RC, Danesh-Meyer H, Savino PJ. Ophthalmology; 2003 Mar; 110(3):539-42. PubMed ID: 12623817 [Abstract] [Full Text] [Related]
6. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA. Clin Exp Rheumatol; 2001 Mar; 19(5):495-501. PubMed ID: 11579707 [Abstract] [Full Text] [Related]
7. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Hayreh SS, Zimmerman B. Ophthalmologica; 2003 Mar; 217(4):239-59. PubMed ID: 12792130 [Abstract] [Full Text] [Related]
8. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B. Ann Intern Med; 2001 Jan 16; 134(2):106-14. PubMed ID: 11177313 [Abstract] [Full Text] [Related]
14. Recovery of vision in a 47-year-old man with fulminant giant cell arteritis. Postel EA, Pollock SC. J Clin Neuroophthalmol; 1993 Dec 16; 13(4):262-70. PubMed ID: 8113439 [Abstract] [Full Text] [Related]
15. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis. Foré R, Liozon E, Dumonteil S, Sené T, Héron E, Lacombe V, Leclercq M, Magnant J, Beuvon C, Régent A, de Mornac D, Samson M, Smets P, Alexandra JF, Granel B, Robert PY, Curumthaullee MF, Parreau S, Palat S, Bezanahary H, Ly KH, Fauchais AL, French study group for large-vessel arteritis (GEFA), Gondran G. Joint Bone Spine; 2024 Jan 16; 91(1):105641. PubMed ID: 37734440 [Abstract] [Full Text] [Related]
16. Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis. Zborowska B, Ell J, McGhee-Collett M, Scolyer R, McCluskey PJ. Clin Exp Ophthalmol; 2004 Jun 16; 32(3):335-6. PubMed ID: 15180851 [Abstract] [Full Text] [Related]